Article (Scientific journals)
Management of osteoporosis of the oldest old.
Rizzoli, R.; Branco, J.; Brandi, M.-L. et al.
2014In Osteoporosis International, 25, p. 2507-2529
Peer Reviewed verified by ORBi
 

Files


Full Text
Management of osteoporosis of the oldest old.pdf
Publisher postprint (1.09 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] This consensus article reviews the diagnosis and treatment of osteoporosis in geriatric populations. Specifically, it reviews the risk assessment and intervention thresholds, the impact of nutritional deficiencies, fall prevention strategies, pharmacological treatments and their safety considerations, the risks of sub-optimal treatment adherence and strategies for its improvement. INTRODUCTION: This consensus article reviews the therapeutic strategies and management options for the treatment of osteoporosis of the oldest old. This vulnerable segment (persons over 80 years of age) stands to gain substantially from effective anti-osteoporosis treatment, but the under-prescription of these treatments is frequent. METHODS: This report is the result of an ESCEO (European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis) expert working group, which explores some of the reasons for this and presents the arguments to counter these beliefs. The risk assessment of older individuals is briefly reviewed along with the differences between some intervention guidelines. The current evidence on the impact of nutritional deficiencies (i.e. calcium, protein and vitamin D) is presented, as are strategies to prevent falls. One possible reason for the under-prescription of pharmacological treatments for osteoporosis in the oldest old is the perception that anti-fracture efficacy requires long-term treatment. However, a review of the data shows convincing anti-fracture efficacy already by 12 months. RESULTS: The safety profiles of these pharmacological agents are generally satisfactory in this patient segment provided a few precautions are followed. CONCLUSION: These patients should be considered for particular consultation/follow-up procedures in the effort to convince on the benefits of treatment and to allay fears of adverse drug reactions, since poor adherence is a major problem for the success of a strategy for osteoporosis and limits cost-effectiveness.
Disciplines :
General & internal medicine
Author, co-author :
Rizzoli, R.
Branco, J.
Brandi, M.-L.
Boonen, S.
Bruyère, Olivier  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cacoub, P.
Cooper, C.
Diez-Perez, A.
Duder, J.
Fielding, R. A.
Harvey, N. C.
Hiligsmann, Mickaël ;  Université de Liège - ULiège > Département des sciences de la santé publique > Département des sciences de la santé publique
Kanis, J. A.
Petermans, Jean ;  Université de Liège - ULiège > Département des sciences cliniques > Gériatrie
Ringe, J. D.
Tsouderos, Y.
Weinman, J.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
More authors (8 more) Less
Language :
English
Title :
Management of osteoporosis of the oldest old.
Publication date :
2014
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer, Germany
Volume :
25
Pages :
2507-2529
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 17 July 2014

Statistics


Number of views
61 (6 by ULiège)
Number of downloads
2 (2 by ULiège)

Scopus citations®
 
62
Scopus citations®
without self-citations
45
OpenCitations
 
60

Bibliography


Similar publications



Contact ORBi